Cullinan Therapeutics, Inc. CGEM Increase Decrease In Accrued Expenses And Other Current Liabilities
Increase Decrease In Accrued Expenses And Other Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept cgem:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s increase decrease in accrued expenses and other current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s increase decrease in accrued expenses and other current liabilities?
- Cullinan Therapeutics, Inc. (CGEM) reported increase decrease in accrued expenses and other current liabilities of -$4.31M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s increase decrease in accrued expenses and other current liabilities changed year-over-year?
- Cullinan Therapeutics, Inc.'s increase decrease in accrued expenses and other current liabilities increased by 18.0% year-over-year, from -$5.26M to -$4.31M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s increase decrease in accrued expenses and other current liabilities?
- Over 3 years (2022 to 2025), Cullinan Therapeutics, Inc.'s increase decrease in accrued expenses and other current liabilities has grown at a -2.0% compound annual growth rate (CAGR), from $8.53M to $8.03M.
- What does increase decrease in accrued expenses and other current liabilities mean?
- This metric represents the net change in short-term liabilities, excluding accounts payable, such as accrued compensation, taxes, or other operational obligations. It reflects the timing difference between when expenses are recognized on the income statement and when the actual cash outflow occurs. A positive change indicates an increase in liabilities, effectively serving as a source of operating cash flow by delaying cash payments.